Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
The Interferons: Mechanisms of Action and Clinical Applications
Samuel Baron
, Stephen K. Tyring
, W. Robert Fleischmann
, Dorian H Coppenhaver
,
David W. Niesel
, Gary R. Klimpel
, G. John Stanton
, Thomas K. Hughes
Microbiology And Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
657
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Interferons: Mechanisms of Action and Clinical Applications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mechanism of Action
100%
Clinical Application
100%
Interferon-α (IFN-α)
100%
Chemotherapy
16%
Tumor
16%
Microbes
16%
Hyperthermia
16%
AIDS/HIV
16%
Human Immunodeficiency Virus Infection
16%
Recent Advances
16%
Combination Therapy
16%
Interferon-γ
16%
Early Humans
16%
Interferon Response
16%
Viral Hepatitis
16%
Kaposi Sarcoma
16%
B-type
16%
Chronic Granulomatous Disease
16%
Antimicrobial Activity
16%
Antiviral Action
16%
Basal Cell Carcinoma
16%
Hepatitis B
16%
Immunosuppressive Therapy
16%
Defensive Response
16%
Immunomodulatory Action
16%
Clinical Indications
16%
Chronic Myeloid Leukemia
16%
Cutaneous Squamous Cell Carcinoma (cSCC)
16%
Laryngeal Papillomatosis
16%
Condyloma Acuminatum
16%
Hairy Cell Leukemia
16%
Antitumor Action
16%
Medicine and Dentistry
Interferon
100%
Combination Therapy
16%
Antivirus Agent
16%
Human Immunodeficiency Virus Infection
16%
Antiinfective Agent
16%
Cytokine
16%
Acquired Immune Deficiency Syndrome
16%
Laryngeal Papillomatosis
16%
Interferon Alfa
16%
Genital Wart
16%
Kaposi Sarcoma
16%
Hyperthermia
16%
Basal-Cell Carcinoma
16%
Hepatitis Virus
16%
Hepatitis B
16%
Gamma Interferon
16%
Skin Carcinoma
16%
Chronic Granulomatous Disease
16%
Chronic Myelogenous Leukemia
16%
Hairy Cell Leukemia
16%
Tumor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Human Immunodeficiency Virus Infection
16%
Antivirus Agent
16%
Chemotherapy
16%
Cytokine
16%
Antiinfective Agent
16%
Combination Therapy
16%
Acquired Immune Deficiency Syndrome
16%
Larynx Papillomatosis
16%
Alpha Interferon
16%
Virus Hepatitis
16%
Gamma Interferon
16%
Hepatitis B
16%
Hyperthermia
16%
Condyloma acuminatum
16%
Skin Carcinoma
16%
Chronic Granulomatous Disease
16%
Kaposi Sarcoma
16%
Chronic Myeloid Leukemia
16%
Basal Cell Carcinoma
16%
Hairy Cell Leukemia
16%
Immunology and Microbiology
interferon
100%
Human Immunodeficiency Virus Infection
16%
Cytokine
16%
Squamous Cell
16%
Leukemia Cell
16%
Interferon Alfa
16%
Acquired Immune Deficiency Syndrome
16%
Hepatitis Virus
16%
Interferon Gamma
16%
Hepatitis B
16%
Basal Cell
16%
Chronic Granulomatous Disease
16%
Condyloma
16%